Evaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents

Basit Öğe Kaydı
dc.contributor.authorOzdemir, Hasan H.
dc.contributor.authorVarol, Sefer
dc.contributor.authorAkil, Esref
dc.contributor.authorAcar, Abdullah
dc.contributor.authorDemir, Caner F.
dc.date.accessioned2024-04-24T16:02:01Z
dc.date.available2024-04-24T16:02:01Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractOur goal was to evaluate the clinical patterns, additional risk factors, treatment and outcome of cerebral venous thrombosis (CVT) related to adolescent oral contraceptive pill (OCP) usage. We evaluated 22 patients with CVT related to OCPs admitted to Firat and Dicle University Hospitals from January 2008 to January 2013. We assessed the clinical features, risk factors, imaging results and prognosis. Magnetic resonance imaging (MRI) and magnetic resonance were the preferred procedures for the diagnosis of CVT. MRI revealed parenchymal lesions in 11 (50 %) patients, and the remaining patients had normal MRIs. The sinuses most frequently affected by thrombosis were the superior sagittal sinus and the transverse sinus. The additional risk factors identified for CVT were antiphospholipid syndrome, protein C deficiency, protein C and S deficiency, factor V Leiden associated with heterozygous antithrombin III deficiency, methylenetetrahydrofolate reductase and prothrombin gene mutations. CVT may be overlooked in adolescents because it is more common among middle-aged and elderly adults. CVT should be suspected in the presence of neurological symptoms in adolescents, especially in those using OCPs.en_US
dc.identifier.doi10.1007/s10072-014-1914-2
dc.identifier.endpage153en_US
dc.identifier.issn1590-1874
dc.identifier.issn1590-3478
dc.identifier.issue1en_US
dc.identifier.pmid25092566
dc.identifier.scopus2-s2.0-84939880630
dc.identifier.scopusqualityQ1
dc.identifier.startpage149en_US
dc.identifier.urihttps://doi.org/10.1007/s10072-014-1914-2
dc.identifier.urihttps://hdl.handle.net/11468/14571
dc.identifier.volume36en_US
dc.identifier.wosWOS:000347287200021
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringer-Verlag Italia Srlen_US
dc.relation.ispartofNeurological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdolescentsen_US
dc.subjectCerebral Venous Thrombosisen_US
dc.subjectOral Contraceptivesen_US
dc.titleEvaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescentsen_US
dc.titleEvaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu